Skip to content
Search

Latest Stories

RPS England, PDA urge government to publish NHS workforce plan

Royal Pharmaceutical Society (RPS) England and Pharmacists Defence Association (PDA) have joined with professional bodies, trade unions and patient groups to call on the government to publish the NHS Long-Term Workforce Plan.

A joint letter signed by almost 40 organisations raises concerns over ongoing delays to the publication of the workforce plan and urges the Prime Minister to take urgent action to help meet current and future patient needs.


English Pharmacy Board Chair Thorrun Govind said: “The range of health and care leaders backing this letter shows just how important it is that the Government acts now to support our workforce.

“It is vital that we recruit and retain the staff we need so we can keep looking after patients.

“When we met NHS England in January, pharmacy leaders called for the plan to include the whole of pharmacy and to recognise the increasing role of pharmacist independent prescribers in our health service.

“With teams under pressure across the system, this workforce plan also needs to support staff retention, secure protected time for learning and development, and ensure continued access to wellbeing services.”

PDA commented: “The workforce plan was originally earmarked for publication in Spring 2022 but has still not been published. Media speculation suggests that there is a disagreement between the Treasury and Department for Health and Social Care on the scale of the staffing needed for the NHS and other sectors.

Meanwhile pharmacists see first hand the impact on patients from understaffing across the health system.  Understaffing also has an adverse impact on the wellbeing of those staff who are in post.”

The signatories have warned the Government that it will take time to resolve this situation. Every day of delay in committing to action pushes back when patients will see the improvements they deserve.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less